ICON Wins Multiple Categories in 2019 CRO Leadership Awards

ICON plc, (NASDAQ: ICLR) a global provider of drug development
and commercialisation services to the pharmaceutical, biotechnology and
medical device industries, has won awards across several categories in
the annual CRO Leadership Awards.


Icon received 2019 CRO Leadership Awards in five categories, each
further divided into three groups a?? Big Pharma, Small Pharma, and
Overall. In three categories, ICON took awards in all three groups.


Winning categories:





Compatibility (Overall, Big Pharma, Small Pharma)






Expertise (Small Pharma)






Phase IV (Overall, Big Pharma, Small Pharma)






Quality (Overall, Big Pharma, Small Pharma)






Reliability (Overall, Big Pharma)





This builds on ICONa??s success in 2018 when the company won a CRO Phase
IV Leadership Award (Overall, Big Pharma).